Os Therapies Incorporated Stock Analysis
| OSTX Stock | 3.02 1.44 32.29% |
OS Therapies Incorporated is undervalued with Real Value of 5.9 and Target Price of 15.0. The main objective of OS Therapies stock analysis is to determine its intrinsic value, which is an estimate of what OS Therapies Incorporated is worth, separate from its market price. There are two main types of OS Therapies' stock analysis: fundamental analysis and technical analysis.
The OS Therapies stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. OS Therapies is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. OSTX Stock trading window is adjusted to America/New York timezone.
OSTX |
OSTX Stock Analysis Notes
About 25.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.32. OS Therapies had not issued any dividends in recent years. To find out more about OS Therapies Incorporated contact the company at 410-297-7793 or learn more at https://ostherapies.com.OS Therapies Investment Alerts
| OS Therapies had very high historical volatility over the last 90 days | |
| OS Therapies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OS Therapies generates negative cash flow from operations | |
| OS Therapies has a frail financial position based on the latest SEC disclosures | |
| About 25.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: BNP Paribas Financial Markets Cuts Stock Holdings in Iovance Biotherapeutics, Inc. - MarketBeat |
OSTX Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.14 M.Technical Drivers
As of the 16th of December 2024, OS Therapies owns the standard deviation of 9.15, and Market Risk Adjusted Performance of 0.1648. In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of OS Therapies, as well as the relationship between them.OS Therapies Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. OS Therapies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for OS Therapies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
OS Therapies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OS Therapies insiders, such as employees or executives, is commonly permitted as long as it does not rely on OS Therapies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OS Therapies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mckean-dieser Avril Suzette over a month ago Insider Trading | ||
Mckean-dieser Avril Suzette over a month ago Insider Trading | ||
Ciccio John over three months ago Acquisition by Ciccio John of 266306 shares of OS THERAPIES at 75000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Ciccio John over three months ago Acquisition by Ciccio John of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Acevedo Christopher P. over three months ago Disposition of tradable shares by Acevedo Christopher P. of OS THERAPIES subject to Rule 16b-3 |
OS Therapies Predictive Daily Indicators
OS Therapies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OS Therapies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
OS Therapies Corporate Filings
| 27th of November 2024 Other Reports | ViewVerify | |
10Q | 15th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 14th of November 2024 Other Reports | ViewVerify | |
S1 | 12th of November 2024 Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
8K | 1st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 29th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 28th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 28th of August 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
OS Therapies Forecast Models
OS Therapies' time-series forecasting models are one of many OS Therapies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OS Therapies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About OSTX Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how OS Therapies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OSTX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OS Therapies. By using and applying OSTX Stock analysis, traders can create a robust methodology for identifying OSTX entry and exit points for their positions.
OS Therapies is entity of United States. It is traded as Stock on NYSE MKT exchange.
Current OSTX Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. OSTX analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. OSTX analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 15.0 | Strong Buy | 3 | Odds |
Most OSTX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand OSTX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of OS Therapies, talking to its executives and customers, or listening to OSTX conference calls.
OSTX Stock Analysis Indicators
OS Therapies Incorporated stock analysis indicators help investors evaluate how OS Therapies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading OS Therapies shares will generate the highest return on investment. By understating and applying OS Therapies stock analysis, traders can identify OS Therapies position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 171.5 K | |
| Common Stock Shares Outstanding | 20.6 M | |
| Total Stockholder Equity | -24 M | |
| Property Plant And Equipment Net | 8050.00 | |
| Cash | 39 K | |
| Accounts Payable | 2.7 M | |
| Net Debt | 14.6 M | |
| 50 Day M A | 3.6789 | |
| Total Current Liabilities | 24.7 M | |
| Non Current Assets Total | 8050.00 |
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.